Boston, MA, United States of America

Rizwan Haq

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Rizwan Haq

Introduction

Rizwan Haq is a notable inventor based in Boston, MA, whose contributions to the field of biomedical research have led to significant advancements in cancer treatment. With a total of three patents to his name, he has made strides in identifying biomarkers and developing combinatorial therapies for melanoma.

Latest Patents

Rizwan Haq’s most recent patents include groundbreaking inventions focused on improving patient responses to cancer therapies. The first patent, titled "Biomarkers Predictive of Anti-Immune Checkpoint Response," is based on the identification of Fbxw7 as a biomarker that predicts responsiveness to anti-immune checkpoint therapies. This discovery could greatly enhance personalized treatment strategies in oncology.

His second patent, "Combinatorial Compositions and Methods for Treatment of Melanoma," details innovative compositions and methods for treating melanomas with activated mutations. This invention encompasses a multi-faceted approach by combining inhibitors of various pathways, such as MAPK, ERK, and EGFR, along with oxidative phosphorylation inhibitors, B-Raf inhibitors, and others. These combinations aim to improve therapeutic efficacy against challenging melanoma cases.

Career Highlights

Throughout his career, Rizwan Haq has been associated with prestigious institutions, including The General Hospital Corporation and The Broad Institute, Inc. His expertise and research focus have positioned him as a leading figure in cancer research, contributing to the scientific community's understanding of therapeutic responses.

Collaborations

Rizwan has had the opportunity to collaborate with esteemed professionals in his field, including David E. Fisher and Patrick Faloon. These collaborations have fostered an environment of innovation and have propelled significant advancements in cancer therapy through shared knowledge and expertise.

Conclusion

Rizwan Haq’s work exemplifies the spirit of innovation within the biomedical sector. His patents not only highlight valuable discoveries but also reflect a commitment to addressing critical challenges in cancer treatment. With ongoing research and collaboration, his contributions continue to pave the way for new therapeutic strategies to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…